The proteasome inhibitor MG132 reduces immobilization-induced skeletal muscle atrophy in mice
2011

MG132 Reduces Muscle Atrophy in Immobilized Mice

Sample size: 8 publication 10 minutes Evidence: moderate

Author Information

Author(s): Caron Annabelle Z, Haroun Sonia, Leblanc Élisabeth, Trensz Frédéric, Guindi Chantal, Amrani Aziz, Grenier Guillaume

Primary Institution: Université de Sherbrooke

Hypothesis

Can the proteasome inhibitor MG132 prevent muscle atrophy caused by immobilization?

Conclusion

The study found that MG132 can prevent muscle atrophy and shorten rehabilitation time after immobilization.

Supporting Evidence

  • MG132 significantly inhibited IκBα degradation.
  • MG132 preserved muscle and myofiber cross-sectional area.
  • MG132 treatment resulted in a diminished rehabilitation period.

Takeaway

This study shows that a special medicine called MG132 can help keep muscles strong when they are not used for a while, making it easier for people to get better after being hurt.

Methodology

Mice were immobilized for 7 days and treated with MG132 or a control substance, followed by assessments of muscle atrophy and recovery.

Limitations

The study was conducted on mice, which may not fully represent human responses.

Participant Demographics

Sixteen-week-old male CD1 mice

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2474-12-185

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication